ctDNA testing post-surgery identifies high-risk stage 3 colon cancer patients more accurately than traditional staging methods. Detectable ctDNA correlates with a four- to six-fold increased risk of ...
SurvivorNet on MSN
One colon cancer expert says the ‘guidelines are behind’ as circulating DNA signals more curable detection of colon cancer recurrence
A phase III trial found that ctDNA-guided surveillance detects colorectal cancer recurrence months earlier than standard CT imaging and more than doubles the chance that recurrence is still curable ...
A sweeping new national consensus has just redrawn the rulebook for one of the fastest-growing frontiers in cancer surgery. The Robotic Surgery Group of the Colorectal Cancer Committee of the Chinese ...
New NCCN guidelines highlight how structured exercise and molecular profiling significantly reduce recurrence rates. Regular exercise is no longer just a recommendation for general health; it is now a ...
Similarly, AZUR-2 is an ongoing global phase III, open-label, randomized trial evaluating perioperative dostarlimab monotherapy (3 months neoadjuvant and 9 months adjuvant) versus standard-of-care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results